SOPHiA GENETICS SA (SOPH) — SEC Filings

Latest SEC filings for SOPHiA GENETICS SA (SOPH), explained in plain English.

Sentiment Overview: 1 bullish, 22 neutral

Recent Filings (23)

• SOPHiA GENETICS SA Files Amended Ownership Report — 4/A · 2026-04-08T08:47:19-04:00 [neutral] Risk: low
  SOPHiA GENETICS SA filed an amended Form 4/A on April 8, 2026, to report changes in beneficial ownership of securities. The filing pertains to the period of rep
• 144 Filing — 144 · 2026-04-06T16:31:59-04:00 [neutral]
• SOPHiA GENETICS SA Files Form 4 for Ownership Changes — 4 · 2026-04-03T06:59:02-04:00 [neutral] Risk: low
  On April 3, 2026, SOPHiA GENETICS SA filed a Form 4, reporting changes in beneficial ownership of securities. The filing pertains to the period of report ending
• SOPHiA GENETICS SA Files Routine 6-K Report — 6-K · 2025-11-04T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on November 4, 2025, for the period ending September 30, 2025. This report is a routine filing for foreign private issuers a
• SOPHiA GENETICS SA Files 6-K with Financial Updates — 6-K · 2025-08-05T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA filed a 6-K report for the period ending June 30, 2025. The filing includes financial data such as issued capital, share premium, treasury sh
• SOPHiA GENETICS SA Shareholders Approve 2024 Financials — 6-K · 2025-06-18T00:00:00.000Z [neutral] Risk: low
  On June 18, 2025, SOPHiA GENETICS SA held its annual general meeting where shareholders approved the 2024 Management Report, Annual Financial Statements, and Co
• SOPHiA GENETICS Releases 2024 ESG Impact Summary — 6-K · 2025-05-16T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on May 16, 2025, to announce the publication of its 2024 Environmental, Social and Governance (ESG) Impact Summary. This sum
• SOPHiA GENETICS SA Sets Annual Shareholder Meeting for June 18 — 6-K · 2025-05-08T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA announced its annual general meeting of shareholders will be held on June 18, 2025, at 8:00 a.m. EDT / 2:00 p.m. CEST in Rolle, Switzerland.
• SOPHiA GENETICS SA Files 6-K for Q1 2025 — 6-K · 2025-05-06T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on May 6, 2025, for the period ending March 31, 2025. This report is incorporated by reference into their existing F-3 regis
• SOPHiA GENETICS SA Files 2024 Annual Report — 20-F · 2025-03-04T00:00:00.000Z [neutral] Risk: medium
  SOPHiA GENETICS SA filed its 20-F annual report for the fiscal year ending December 31, 2024. The company, incorporated in V8 and headquartered in Rolle, Switze
• SC 13G/A Filing — SC 13G/A · 2024-11-13T00:00:00.000Z [neutral]
• SOPHiA GENETICS SA Files 6-K Report — 6-K · 2024-11-05T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on November 5, 2024, for the period ending September 30, 2024. This report is a submission under Rule 13a-16 or 15d-16 of th
• SOPHiA GENETICS SA Files 6-K with Mid-Year Financials — 6-K · 2024-08-06T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA filed a 6-K report for the period ending June 30, 2024. The filing includes financial data for the first six months of 2024 and the second qu
• SOPHiA GENETICS SA Annual Meeting Approves 2023 Financials — 6-K · 2024-06-25T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA held its annual general meeting on June 24, 2024. Shareholders approved the 2023 Management Report, Annual Financial Statements, and Consolid
• SOPHiA GENETICS SA Reports 2024 AGM Results — 6-K · 2024-06-24T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA announced the results of its 2024 Annual General Meeting held on June 24, 2024. Key resolutions included the approval of the annual accounts,
• SOPHiA GENETICS Releases 2023 ESG Impact Summary — 6-K · 2024-06-07T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on June 7, 2024, to announce the publication of its Environmental, Social, and Governance (ESG) Impact Summary for the year
• SOPHiA GENETICS Schedules Annual Shareholder Meeting for June 24 — 6-K · 2024-05-15T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA announced its annual general meeting of shareholders will be held on June 24, 2024, at 8:00 a.m. EDT / 2:00 p.m. CEST. The meeting will take
• SOPHiA GENETICS SA Files Form 6-K — 6-K · 2024-05-07T00:00:00.000Z [neutral] Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on May 7, 2024, reporting on its activities for the month of May 2024. The filing includes information incorporated by refer
• SOPHiA GENETICS SA Files 20-F Annual Report for Fiscal Year 2023 — 20-F · 2024-03-05T00:00:00.000Z [neutral] Risk: medium
  SOPHiA GENETICS SA (SOPH) filed a Foreign Annual Report (20-F) with the SEC on March 5, 2024. SOPHiA GENETICS SA filed its 20-F annual report on March 5, 2024,
• SC 13G/A Filing — SC 13G/A · 2024-02-20T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-02-14T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• SOPHiA GENETICS Touts Growth, 315K+ Analyses at J.P. Morgan Conf. — 6-K · 2024-01-10T00:00:00.000Z [bullish]
  SOPHiA GENETICS (Nasdaq: SOPH) is highlighting its near-term growth strategy at the 42nd annual J.P. Morgan Healthcare Conference on January 11, 2024. The compa